These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

562 related articles for article (PubMed ID: 36982816)

  • 1. Biotherapy Using Probiotics as Therapeutic Agents to Restore the Gut Microbiota to Relieve Gastrointestinal Tract Inflammation, IBD, IBS and Prevent Induction of Cancer.
    Dahiya D; Nigam PS
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
    Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T
    J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut dysbiosis and irritable bowel syndrome: The potential role of probiotics.
    Principi N; Cozzali R; Farinelli E; Brusaferro A; Esposito S
    J Infect; 2018 Feb; 76(2):111-120. PubMed ID: 29291933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging Role of the Gut Microbiome in Irritable Bowel Syndrome.
    Singh P; Lembo A
    Gastroenterol Clin North Am; 2021 Sep; 50(3):523-545. PubMed ID: 34304786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiota and therapeutic approaches for dysbiosis in irritable bowel syndrome: recent developments and future perspectives.
    Dale HF; Lied GA
    Turk J Med Sci; 2020 Nov; 50(SI-2):1632-1641. PubMed ID: 32222124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysbiosis in Functional Bowel Disorders.
    Enck P; Mazurak N
    Ann Nutr Metab; 2018; 72(4):296-306. PubMed ID: 29694952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut Microbiota Dysbiosis as Risk and Premorbid Factors of IBD and IBS Along the Childhood-Adulthood Transition.
    Putignani L; Del Chierico F; Vernocchi P; Cicala M; Cucchiara S; Dallapiccola B;
    Inflamm Bowel Dis; 2016 Feb; 22(2):487-504. PubMed ID: 26588090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysbiosis in Irritable Bowel Syndrome.
    Abraham P; Pratap N
    J Assoc Physicians India; 2023 Sep; 71(9):75-81. PubMed ID: 38700306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic-Therapy-Induced Gut Dysbiosis Affecting Gut Microbiota-Brain Axis and Cognition: Restoration by Intake of Probiotics and Synbiotics.
    Dahiya D; Nigam PS
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory Bowel Diseases and Gut Microbiota.
    Haneishi Y; Furuya Y; Hasegawa M; Picarelli A; Rossi M; Miyamoto J
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
    Stecher B
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probiotics and gut health.
    Scarpellini E; Basilico M; Rinninella E; Carbone F; Schol J; Rasetti C; Abenavoli L; Santori P
    Minerva Gastroenterol (Torino); 2021 Dec; 67(4):314-325. PubMed ID: 33978391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding the Gut Microbiota in Inflammatory and Functional Gastrointestinal Diseases.
    Sundin J; Öhman L; Simrén M
    Psychosom Med; 2017 Oct; 79(8):857-867. PubMed ID: 28422780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiota, dysbiosis and colon lavage.
    Drago L; Valentina C; Fabio P
    Dig Liver Dis; 2019 Sep; 51(9):1209-1213. PubMed ID: 31358483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The gut microbiome and irritable bowel syndrome: State of art review.
    Salem AE; Singh R; Ayoub YK; Khairy AM; Mullin GE
    Arab J Gastroenterol; 2018 Sep; 19(3):136-141. PubMed ID: 29935865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Microbiota and irritable bowel syndrome: A critical inventory].
    Enck P; Mazurak N
    Z Gastroenterol; 2019 Jul; 57(7):859-870. PubMed ID: 31288282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unraveling mechanistic insights into the role of microbiome in neurogenic hypertension: A comprehensive review.
    Dai Y; Shen Z; Khachatryan LG; Vadiyan DE; Karampoor S; Mirzaei R
    Pathol Res Pract; 2023 Sep; 249():154740. PubMed ID: 37567034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of gut microbiota-bile acids axis by probiotics in inflammatory bowel disease.
    Li L; Liu T; Gu Y; Wang X; Xie R; Sun Y; Wang B; Cao H
    Front Immunol; 2022; 13():974305. PubMed ID: 36211363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbiota in health and irritable bowel syndrome: current knowledge, perspectives and therapeutic options.
    Bonfrate L; Tack J; Grattagliano I; Cuomo R; Portincasa P
    Scand J Gastroenterol; 2013 Sep; 48(9):995-1009. PubMed ID: 23964766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome.
    Harris LA; Baffy N
    Postgrad Med; 2017 Nov; 129(8):872-888. PubMed ID: 28936910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.